PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation (Q37166823)

18 August 2017

PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation (English)

1 reference

18 August 2017

1 reference

8

Klaus Klaushofer

1 reference

18 August 2017

Todd A Theman

1

1 reference

18 August 2017

Michael T Collins

2

1 reference

18 August 2017

David W Dempster

3

1 reference

18 August 2017

Hua Zhou

4

1 reference

18 August 2017

James C Reynolds

5

1 reference

18 August 2017

Jaime S Brahim

6

1 reference

18 August 2017

Paul Roschger

7

1 reference

18 August 2017

Karen K Winer

9

1 reference

18 August 2017

1 May 2009

1 reference

Journal of Bone and Mineral Research

18 August 2017

1 reference

18 August 2017

24

1 reference

18 August 2017

5

1 reference

18 August 2017

964-973

1 reference

Bone mineralization density distribution in health and disease.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Normative data for iliac bone histomorphometry in growing children.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Extracellular Ca2+ sensing, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Role of the Ca(2+)-sensing receptor in divalent mineral ion homeostasis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Bone mineral density in patients with familial hypocalciuric hypercalcaemia (FHH)

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Effect of parathyroid hormone administration in a patient with severe hypoparathyroidism caused by gain-of-function mutation of calcium-sensing receptor

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months increases cancellous bone formation and improves cancellous architecture: a study of iliac crest biopsies using histomorphometry and micro computed tomography

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2672210

Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study

3 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Effects of Intermittent Parathyroid Hormone Administration on Bone Mineralization Density in Iliac Crest Biopsies from Patients with Osteoporosis: A Paired Study before and after Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Evaluation of serum osteocalcin as an index of altered bone metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

High Ca2+ inhibits peptide hormone-dependent cAMP production specifically in thick ascending limbs of Henle

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

The effect of aging on bone composition of female Fischer 344 rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Intermittent parathyroid hormone treatment can promote linear growth in the ovariectomized growing rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/19063686

12 December 2020

Identifiers

DOI

10.1359/JBMR.081233

1 reference

release_uoam6ucobrc6dpj2c465oelzea

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uoam6ucobrc6dpj2c465oelzea

24 November 2022

mapped directly with Wikidata item

1 reference

18 August 2017

PubMed publication ID

19063686

1 reference